Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Ultrasound contrast agents and methods of making and using them|
|Abstract:||Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. They contain surfactants and, optionally, hydrophilic stabilizers. The surfactants can be in the form of liposomes. The suspensions are obtained by exposing the surfactants to air or a gas before or after admixing with an aqueous phase. One can impart outstanding resistance against collapse under pressure to these gas-filled microbubbles used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003. Contrast agents with particular mixtures of gases are also disclosed that have advantageous properties.|
|Inventor(s):||Schneider; Michel (Troinex, CH), Yan; Feng (Carouge, CH), Grenier; Pascal (late of Ambilly, FR), Puginier; Jerome (Le Chable-Beaumont, FR), Barrau; Marie-Bernadette (Geneve, CH), Bussat; Philippe (Feigeres, FR), Hybl; Eva (Heidelberg, DE), Bichon; Daniel (Montpellier, FR)|
|Assignee:||Bracco International B.V. (Amsterdam, NL)|
|Filing Date:||Sep 22, 1999|
|Claims:||1. An ultrasound contrast agent comprising an aqueous solution and phospholipid stabilized microbubbles, the phospholipid stabilized microbubbles containing gas comprising a freon wherein the gas is stabilized by phospholipids in lamellar or laminar form at the gas/liquid interface. |
2. The ultrasound contrast agent of claim 1 wherein the gas further comprises nitrogen.
3. The ultrasound contrast agent of claim 1, wherein the phospholipids comprise saturated synthetic lecithin.
4. The ultrasound contrast agent of claim 1, wherein the phospholipids comprise dipalmitoylphosphatidylcholine.
5. The ultrasound contrast agent of claim 1, wherein the phospholipids comprise dipalmitoylphosphatidic acid.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.